Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KRMD NASDAQ:MBOT NYSE:MLSS NASDAQ:SGHT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKRMDKORU Medical Systems$3.92-2.5%$3.81$1.86▼$5.05$185.87M0.5768,255 shs53,620 shsMBOTMicrobot Medical$4.05+4.1%$3.13$0.85▼$4.67$177.17M1.226.21 million shs4.05 million shsMLSSMilestone Scientific$0.59$0.60$0.38▼$1.39$46.35M0.94200,729 shs43,232 shsSGHTSight Sciences$3.46-4.4%$3.75$2.03▼$7.03$189.57M2.46104,883 shs97,070 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKRMDKORU Medical Systems-2.49%-3.45%-8.84%+21.36%+56.18%MBOTMicrobot Medical+4.11%+10.66%+33.22%+73.08%+336.61%MLSSMilestone Scientific0.00%-4.39%-1.98%-32.95%-38.86%SGHTSight Sciences-4.42%-6.23%-18.59%-16.22%-47.42%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKRMDKORU Medical Systems$3.92-2.5%$3.81$1.86▼$5.05$185.87M0.5768,255 shs53,620 shsMBOTMicrobot Medical$4.05+4.1%$3.13$0.85▼$4.67$177.17M1.226.21 million shs4.05 million shsMLSSMilestone Scientific$0.59$0.60$0.38▼$1.39$46.35M0.94200,729 shs43,232 shsSGHTSight Sciences$3.46-4.4%$3.75$2.03▼$7.03$189.57M2.46104,883 shs97,070 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKRMDKORU Medical Systems-2.49%-3.45%-8.84%+21.36%+56.18%MBOTMicrobot Medical+4.11%+10.66%+33.22%+73.08%+336.61%MLSSMilestone Scientific0.00%-4.39%-1.98%-32.95%-38.86%SGHTSight Sciences-4.42%-6.23%-18.59%-16.22%-47.42%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKRMDKORU Medical Systems 3.00Buy$4.6317.98% UpsideMBOTMicrobot Medical 2.50Moderate Buy$12.00196.30% UpsideMLSSMilestone Scientific 3.00Buy$1.25111.86% UpsideSGHTSight Sciences 2.43Hold$4.4227.65% UpsideCurrent Analyst Ratings BreakdownLatest MLSS, MBOT, SGHT, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/11/2025MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $12.008/28/2025SGHTSight SciencesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold8/21/2025MBOTMicrobot MedicalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/21/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$3.60 ➝ $4.508/8/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.00 ➝ $5.007/15/2025SGHTSight SciencesMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$3.00 ➝ $4.006/18/2025SGHTSight SciencesPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$3.50 ➝ $4.00(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKRMDKORU Medical Systems$36.85M4.92N/AN/A$0.37 per share10.59MBOTMicrobot MedicalN/AN/AN/AN/A$0.17 per shareN/AMLSSMilestone Scientific$9.08M5.10N/AN/A$0.11 per share5.36SGHTSight Sciences$79.87M2.27N/AN/A$1.72 per share2.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKRMDKORU Medical Systems-$6.07M-$0.09N/AN/AN/A-12.24%-26.77%-16.81%11/12/2025 (Estimated)MBOTMicrobot Medical-$11.44M-$0.58N/AN/AN/AN/A-76.27%-67.54%11/12/2025 (Estimated)MLSSMilestone Scientific-$6.93M-$0.09N/A∞N/A-52.01%-60.26%-40.23%N/ASGHTSight Sciences-$51.51M-$0.96N/AN/AN/A-64.23%-59.38%-36.43%11/6/2025 (Estimated)Latest MLSS, MBOT, SGHT, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025MBOTMicrobot Medical-$0.08-$0.10-$0.02-$0.10$1.00 millionN/A8/7/2025Q2 2025SGHTSight Sciences-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million8/6/2025Q2 2025KRMDKORU Medical Systems-$0.03$0.01+$0.04N/A$9.46 million$10.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKRMDKORU Medical SystemsN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKRMDKORU Medical Systems0.012.912.25MBOTMicrobot MedicalN/A12.0612.06MLSSMilestone ScientificN/A2.851.86SGHTSight Sciences0.5710.019.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKRMDKORU Medical Systems58.60%MBOTMicrobot Medical16.30%MLSSMilestone Scientific5.79%SGHTSight Sciences55.51%Insider OwnershipCompanyInsider OwnershipKRMDKORU Medical Systems20.60%MBOTMicrobot Medical4.74%MLSSMilestone Scientific24.75%SGHTSight Sciences30.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKRMDKORU Medical Systems8046.24 million36.71 millionOptionableMBOTMicrobot Medical2045.55 million43.39 millionOptionableMLSSMilestone Scientific3078.56 million58.61 millionOptionableSGHTSight Sciences21052.37 million36.19 millionOptionableMLSS, MBOT, SGHT, and KRMD HeadlinesRecent News About These CompaniesSight Sciences, Inc. (SGHT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10 at 6:03 PM | seekingalpha.comSight Sciences, Inc. (NASDAQ:SGHT) Receives $4.42 Average Target Price from AnalystsSeptember 10 at 2:33 AM | americanbankingnews.comSight Sciences, Inc.: Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | finanznachrichten.deSight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | finance.yahoo.comSight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare's® Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from AnalystsSeptember 8, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Downgraded to "Sell" Rating by Wall Street ZenSeptember 8, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Stock Rating Lowered by Wall Street ZenSeptember 7, 2025 | americanbankingnews.comSight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJOSeptember 2, 2025 | globenewswire.comSight Sciences, Inc. $SGHT Shares Purchased by Long Focus Capital Management LLCSeptember 1, 2025 | marketbeat.comSight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare ConferenceAugust 26, 2025 | globenewswire.comWhat 4 Analyst Ratings Have To Say About Sight SciencesAugust 22, 2025 | benzinga.comSight Sciences price target raised to $4.50 from $3.60 at CitiAugust 21, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by BrokeragesAugust 14, 2025 | marketbeat.comSight Sciences’ Earnings Call: Balancing Growth and ChallengesAugust 13, 2025 | msn.comLake Street Upgrades Sight Sciences (SGHT)August 11, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comSight Sciences, Inc. (SGHT) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSight Sciences Reports Q2 2025 Financial ResultsAugust 8, 2025 | tipranks.comCompared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key MetricsAugust 7, 2025 | zacks.comSight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue EstimatesAugust 7, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025The Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 2025MLSS, MBOT, SGHT, and KRMD Company DescriptionsKORU Medical Systems NASDAQ:KRMD$3.92 -0.10 (-2.49%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.92 0.00 (0.00%) As of 09/12/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Microbot Medical NASDAQ:MBOT$4.05 +0.16 (+4.11%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$4.03 -0.02 (-0.62%) As of 09/12/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Milestone Scientific NYSE:MLSS$0.59 0.00 (-0.34%) As of 09/12/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Sight Sciences NASDAQ:SGHT$3.46 -0.16 (-4.42%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.46 0.00 (0.00%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
